Background Limited evidence exists on the role of glucose-lowering drugs in patients with
COVID-19. Our main objective was to examine the association between in-hospital death and …

(1) Background: Different clinical presentations in COVID-19 are described to date, from
mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 …

Context. Calcifediol has been proposed as a potential treatment for COVID-19 patients.
Objective: To compare the administration or not of oral calcifediol on mortality risk of patients …

Background The impact of statins on COVID-19 outcomes is important given the high
prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess …

The term leishmaniasis comprises a group of diseases caused by different species of a
protozoon called Leishmania. Leishmaniasis is found worldwide, and is considered to be …

Background COVID-19 severely impacted older adults and long-term care facility (LTCF)
residents. Our primary aim was to describe differences in clinical and epidemiological variables…

Background Age is a risk factor for COVID severity. Most studies performed in hospitalized
patients with SARS-CoV2 infection have shown an over-representation of older patients and …

Background The inflammatory cascade is the main cause of death in COVID-19 patients.
Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which …

Objetivo Evaluar el uso de la terapia con beneficio cardiovascular en pacientes con DM tipo
2 previo al ingreso en servicios de medicina interna. Métodos Estudio transversal en un día …

Objective: To compare coronavirus disease 2019 (COVID-19) hospitalization outcomes
between persons with and without HIV. Design: Retrospective observational cohort study in 150 …